Actively Recruiting
Evaluating Safety and Efficacy of Different Doses of Oral Lipase NHS7108 Compared to Pancrelipase in Adults with Exocrine Pancreatic Insufficiency
Led by Aimmune Nestlé Health Science US R&D, LLC · Updated on 2026-10-01
66
Participants Needed
39
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and exploring the effectiveness of four different doses of a new lipase called NHS7108 in adults with exocrine pancreatic insufficiency EPI. This condition involves difficulty digesting fats and proteins due to a lack of pancreatic enzymes. The study is a Phase 2a randomized, open-label, crossover trial comparing NHS7108 to the standard treatment, pancrelipase Zenpepae. Participants will stop their usual enzyme treatments during the study to allow accurate assessment of the study drugs. Participants will take either NHS7108 or Zenpepae capsules orally with three main meals and two snacks daily for two consecutive 14-day treatment periods, without a washout between them. The doses of NHS7108 vary across four groups from very low to high, adjusted by weight if necessary, with matching doses of Zenpepae. During screening and each treatment period, participants will stay in a controlled setting for about 7 days to follow a standardized diet and collect stool samples for analysis. Outside these periods, participants will manage their own meals at home based on provided guidelines. Throughout the study, which lasts about 14 weeks including screening, treatment, and follow-up, participants will undergo assessments including stool collections, blood tests to measure fat absorption, and physical examinations. Safety will be closely monitored, especially focusing on the coefficient of nitrogen absorption. An end-of-study safety follow-up visit occurs about two weeks after the last dose. The study aims to enroll approximately 66 participants to have 56 complete the trial.
CONDITIONS
Brief Title
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
Research Team
S
Sandrine Guillot
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here